- The researchers found that, in mice, blocking EP2 with a drug reversed memory loss and myriad other Alzheimer’s-like features in the animals.
- By 2015 there will be 850,000 people with dementia in the UK, with Alzheimer’s disease being the most common.The disease kills at least 60,000 people each year.
- Now Stanford is hoping to produce a compound which only blocks EP2 to prevent unnecessary side effects.